Stock CYBN CLARMIN EXPLORATIONS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Clarmin Explorations Inc. Toronto S.E.

Equities

CYBN

CA23256X1006

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN)
AQ
A Swell Of Insider Purchases Follow Cybin Inc.'s Positive Year-End Update
NE
Cybin : Meeting and Record of Notice Form 6 K
PU
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
BU
Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
BU
Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development
CI
Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development
BU
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
BU
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
BU
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
AQ
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones 
BU
Cybin Provides Corporate Provides Update Highlighting Recent Clinical Accomplishments and Key Upcoming Catalysts Across Its Development Pipeline
CI
Cybin to Participate at the 27th Annual Milken Institute Global Conference
BU
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
BU
Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003
MT
Cybin Secures US Patent for CYB003 Program in Major Depressive Disorder Treatment
MT
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
BU
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
BU
Cybin : MATERIAL CHANGE REPORT - Form 6-K
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYBN Stock
  4. CYBN Stock
  5. News Clarmin Explorations Inc.